{"id":"apremilast-modified-release-13","safety":{"commonSideEffects":[{"rate":"12%","effect":"Diarrhea"},{"rate":"10%","effect":"Nausea"},{"rate":"8%","effect":"Headache"}]},"_chembl":{"chemblId":"CHEMBL514800","moleculeType":"Small molecule","molecularWeight":"460.51"},"_dailymed":null,"mechanism":{"_ai_source":"featherless-qwen","explanation":"By inhibiting PDE4, apremilast reduces the production of pro-inflammatory mediators and increases the production of anti-inflammatory mediators, thereby modulating the immune response and reducing inflammation.","oneSentence":"Apremilast is a small molecule inhibitor of phosphodiesterase 4 (PDE4), which leads to increased intracellular levels of cyclic adenosine monophosphate (cAMP).","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T04:34:52.989Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Plaque psoriasis"},{"name":"Psoriatic arthritis"}]},"trialDetails":[{"nctId":"NCT02236988","phase":"PHASE1","title":"Study to Evaluate Pharmacokinetics of Prototype Modified-Release Formulations Of Apremilast in Healthy Men","status":"COMPLETED","sponsor":"Amgen","startDate":"2014-01-07","conditions":"Healthy Volunteers","enrollment":80}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_1","status":"active","brandName":"Apremilast Modified Release 13","genericName":"Apremilast Modified Release 13","companyName":"Amgen","companyId":"amgen","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Apremilast is a small molecule inhibitor of phosphodiesterase 4 (PDE4), which leads to increased intracellular levels of cyclic adenosine monophosphate (cAMP). Used for Plaque psoriasis, Psoriatic arthritis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}